| Product Information |
|
| Registration Number |
BR-1467
|
| Generic Name |
Avelumab
|
| Brand Name |
Bavencio
|
| Dosage Strength |
200 mg/10 mL (20 mg/mL)
|
| Dosage Form |
Concentrate for Solution for
Infusion (IV)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
200 mg/10 mL (20 mg/mL)
|
| Pharmacologic Category |
Monoclonal Antibodies
|
| Manufacturer |
Merck Serono SA
|
| Country of Origin |
Switzerland
|
| Trader |
|
| Importer |
Merck, Inc.
|
| Distributor |
Merck, Inc.
|
| Application Type |
Monitored Release (MR)
|
| Issuance Date |
22 February 2024
|
| Expiry Date |
22 February 2029
|